AAA
ONC

Affinity Asset Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Affinity Asset Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-35,000
Closed -$7.86M – 106
2024
Q3 		$7.86M Sell
35,000
-75,000
-68% -$13.5M 1.07% 29
2024
Q2 		$15.7M Buy
110,000
+27,857
+34% +$4.29M 1.81% 14
2024
Q1 		$12.8M Buy
+82,143
New +$13.2M 1.59% 18

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Affinity Asset Advisors's ONC Position: Q4 2024 in Review

Affinity Asset Advisors sold out of BeOne Medicines Ltd (ONC) in Q4 2024, closing a stake of 35,000 shares — an estimated $7.86M sold.

Affinity Asset Advisors first reported a position in ONC in Q1 2024 and held it in 3 quarters. The position peaked at $15.7M in Q2 2024. 227 funds tracked by Wall St. Rank hold ONC as of Q4 2024.

  • Affinity Asset Advisors reported no remaining BeOne Medicines Ltd position as of Q4 2024 after selling out during the quarter.
  • Affinity Asset Advisors sold 35,000 BeOne Medicines Ltd shares in Q4 2024, an estimated $7.86M.
  • Affinity Asset Advisors first reported a position in BeOne Medicines Ltd in Q1 2024 and held it in 3 quarters.
  • Affinity Asset Advisors's BeOne Medicines Ltd position peaked at $15.7M in Q2 2024.
  • 227 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2024.

Based on Affinity Asset Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.